Compile Data Set for Download or QSAR
Report error Found 108 Enz. Inhib. hit(s) with all data for entry = 50014927
LigandPNGBDBM50581180(CHEMBL5081214)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581182(CHEMBL5080391)
Affinity DataIC50: 0.126nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581183(CHEMBL5087564)
Affinity DataIC50: 0.158nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581184(CHEMBL5094110)
Affinity DataIC50: 0.251nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581181(CHEMBL5086895)
Affinity DataIC50: 0.316nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581185(CHEMBL5076558)
Affinity DataIC50: 0.316nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581197(CHEMBL5077250)
Affinity DataIC50: 0.316nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581192(CHEMBL5091461)
Affinity DataIC50: 0.501nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581195(CHEMBL5085166)
Affinity DataIC50: 0.631nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581196(CHEMBL5086272)
Affinity DataIC50: 0.631nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581204(CHEMBL5076637)
Affinity DataIC50: 0.631nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581204(CHEMBL5076637)
Affinity DataIC50: 0.631nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325605(US9636336, Example 23 | US9636336, Example 86 | [(...)
Affinity DataIC50: 0.794nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581198(CHEMBL5086769)
Affinity DataIC50: 0.794nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325605(US9636336, Example 23 | US9636336, Example 86 | [(...)
Affinity DataIC50: 0.794nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581179(CHEMBL5078680)
Affinity DataIC50: 1nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
LigandPNGBDBM50581186(CHEMBL5088742)
Affinity DataIC50: 1nMAssay Description:Inhibition of PDE4 in human U-937 cells assessed as reduction in cAMP level by LANCE cAMP AssayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581191(CHEMBL5070876)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581193(CHEMBL5084383)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581206(CHEMBL5076886)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581206(CHEMBL5076886)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325606(US9636336, Example 87c)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325606(US9636336, Example 87c)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581208(CHEMBL5076535)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581208(CHEMBL5076535)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581207(CHEMBL5074216)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581207(CHEMBL5074216)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581203(CHEMBL5074599)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581203(CHEMBL5074599)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581187(CHEMBL5077161)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581205(CHEMBL5077424)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581205(CHEMBL5077424)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325621(US9636336, Example 11 | [(1S)-2-(3,5-dichloro-1-ox...)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325621(US9636336, Example 11 | [(1S)-2-(3,5-dichloro-1-ox...)
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581203(CHEMBL5074599)
Affinity DataIC50: 2nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581203(CHEMBL5074599)
Affinity DataIC50: 2nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581189(CHEMBL5075132)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325637(US9636336, Example 28 | [(1S)-2-(3,5-dichloro-1-ox...)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325637(US9636336, Example 28 | [(1S)-2-(3,5-dichloro-1-ox...)
Affinity DataIC50: 2.51nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581207(CHEMBL5074216)
Affinity DataIC50: 3.16nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581207(CHEMBL5074216)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581185(CHEMBL5076558)
Affinity DataIC50: 3.98nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581185(CHEMBL5076558)
Affinity DataIC50: 4nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581186(CHEMBL5088742)
Affinity DataIC50: 6.30nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581190(CHEMBL5076266)
Affinity DataIC50: 7.90nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581188(CHEMBL5076680)
Affinity DataIC50: 10nMAssay Description:Inhibition of human recombinant PDE4B2 assessed as reduction in cAMP level incubated for 2 hrs by LANCE Ultra cAMP TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM50581206(CHEMBL5076886)
Affinity DataIC50: 10nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325606(US9636336, Example 87c)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325606(US9636336, Example 87c)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMuscarinic acetylcholine receptor M3(Rat)
Chiesi Farmaceutici

Curated by ChEMBL
LigandPNGBDBM325621(US9636336, Example 11 | [(1S)-2-(3,5-dichloro-1-ox...)
Affinity DataIC50: 20nMAssay Description:Antagonist activity at muscarinic M3 receptor in rat trachea assessed as inhibition of carbachol-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
Displayed 1 to 50 (of 108 total ) | Next | Last >>
Jump to: